Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-24-108596
Filing Date
2024-10-15
Accepted
2024-10-15 16:19:38
Documents
2
Group Members
CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2426185d1_sc13d.htm SC 13D 107230
2 EXHIBIT 99.5 tm2426185d1_ex99-5.htm EX-99.5 3940
  Complete submission text file 0001104659-24-108596.txt   112919
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Subject) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92238 | Film No.: 241372053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2 DAI FU ST., TAI PO INDUSTRIAL ESTATE NEW TERRITORIES HONG KONG K3 00000
Business Address 2 DAI FU ST., TAI PO INDUSTRIAL ESTATE NEW TERRITORIES HONG KONG K3 00000 (852) 2126 1661
Sealbond Ltd (Filed by) CIK: 0002040446 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D